Quince Therapeutics, Inc. Common Stock (QNCX) is a publicly traded Healthcare sector company. As of July 29, 2026, QNCX trades at $18.97 with a market cap of $17.46M and a P/E ratio of -10.77. QNCX moved +0.00% today. Year to date, QNCX is -97.11%; over the trailing twelve months it is -94.62%. Its 52-week range spans $15.10 to $909.98. Analyst consensus is strong buy with an average price target of $86.67. Rallies surfaces QNCX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks QNCX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $18.97 |
| Market Cap | $17.46M |
| P/E Ratio | -10.77 |
| EPS | $-1.68 |
| Dividend Yield | 0.00% |
| 52-Week High | $909.98 |
| 52-Week Low | $15.10 |
| Volume | 8.49K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-80.77M |
| Gross Margin | 0.00% |
3 analysts cover QNCX: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $86.67.